PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7526541-8	1994	Blockade of TNF-alpha by a pentoxifylline treatment led to the decrease of IL-1 and iNOS expression accompanied by a reduction of the volume of the lesions indicating that the Tat-induced lesions might be mediated by TNF production.	Pentoxifylline	27-41	tumor necrosis factor	Mus musculus	12-21	
7526541-8	1994	Blockade of TNF-alpha by a pentoxifylline treatment led to the decrease of IL-1 and iNOS expression accompanied by a reduction of the volume of the lesions indicating that the Tat-induced lesions might be mediated by TNF production.	Pentoxifylline	27-41	interleukin 1 complex	Mus musculus	75-79	
7526541-8	1994	Blockade of TNF-alpha by a pentoxifylline treatment led to the decrease of IL-1 and iNOS expression accompanied by a reduction of the volume of the lesions indicating that the Tat-induced lesions might be mediated by TNF production.	Pentoxifylline	27-41	nitric oxide synthase 2, inducible	Mus musculus	84-88	
7526541-8	1994	Blockade of TNF-alpha by a pentoxifylline treatment led to the decrease of IL-1 and iNOS expression accompanied by a reduction of the volume of the lesions indicating that the Tat-induced lesions might be mediated by TNF production.	Pentoxifylline	27-41	tyrosine aminotransferase	Mus musculus	176-179	
7526541-8	1994	Blockade of TNF-alpha by a pentoxifylline treatment led to the decrease of IL-1 and iNOS expression accompanied by a reduction of the volume of the lesions indicating that the Tat-induced lesions might be mediated by TNF production.	Pentoxifylline	27-41	tumor necrosis factor	Mus musculus	12-15